HealthEquity Price to Sales Ratio 2014-2025 | HQY

Historical PS ratio values for HealthEquity (HQY) over the last 10 years. The current P/S ratio for HealthEquity as of May 30, 2025 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
HealthEquity P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2025-05-30 100.61 7.43
2025-01-31 110.42 $13.54 8.16
2024-10-31 85.25 $13.05 6.53
2024-07-31 78.48 $12.52 6.27
2024-04-30 78.91 $11.95 6.60
2024-01-31 75.58 $11.54 6.55
2023-10-31 71.68 $11.29 6.35
2023-07-31 67.94 $10.98 6.19
2023-04-30 53.45 $10.60 5.04
2023-01-31 60.85 $10.21 5.96
2022-10-31 77.91 $9.89 7.88
2022-07-31 58.17 $9.49 6.13
2022-04-30 62.32 $9.31 6.69
2022-01-31 53.44 $9.12 5.86
2021-10-31 66.18 $9.16 7.23
2021-07-31 73.98 $9.31 7.95
2021-04-30 75.97 $9.48 8.02
2021-01-31 83.55 $9.85 8.48
2020-10-31 51.49 $10.30 5.00
2020-07-31 51.56 $10.23 5.04
2020-04-30 56.27 $9.12 6.17
2020-01-31 66.06 $7.85 8.42
2019-10-31 56.79 $6.11 9.30
2019-07-31 81.98 $4.98 16.46
2019-04-30 67.75 $4.78 14.17
2019-01-31 62.34 $4.53 13.75
2018-10-31 91.80 $4.32 21.27
2018-07-31 75.50 $4.13 18.28
2018-04-30 65.67 $3.93 16.71
2018-01-31 50.62 $3.72 13.61
2017-10-31 50.22 $3.52 14.25
2017-07-31 45.87 $3.33 13.79
2017-04-30 45.52 $3.15 14.47
2017-01-31 46.25 $2.99 15.49
2016-10-31 33.23 $2.81 11.81
2016-07-31 29.52 $2.61 11.32
2016-04-30 25.15 $2.38 10.55
2016-01-31 21.55 $2.16 9.98
2015-10-31 32.71 $2.03 16.12
2015-07-31 33.66 $1.89 17.78
2015-04-30 26.21 $1.88 13.96
Sector Industry Market Cap Revenue
Medical Medical Services $8.734B $1.200B
HealthEquity provides integrated solutions for health-care account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States. HealthEquity's flagship health savings account or HSA is a financial account through which consumers spend and save for the long term for healthcare on a tax-advantaged basis. This has provided the company with a competitive edge in the MedTech industry. Other than HSAs, the company offers Healthcare saving and spending platform, Investment platform and advisory services and Reimbursement arrangements. In addition, HealthEquity offers health reimbursement and flexible spending arrangements solutions; Employee Retirement Income Security Act's plan administration and investment services.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $136.314B 25.57
Elevance Health (ELV) United States $85.975B 11.09
CVS Health (CVS) United States $79.418B 9.87
Cencora (COR) United States $56.343B 19.60
DiDi Global (DIDIY) China $22.968B 34.86
Natera (NTRA) United States $21.581B 0.00
BioMerieux (BMXMF) France $15.705B 0.00
Solventum (SOLV) United States $12.562B 13.30
EUROFINS SCIENT (ERFSF) Luxembourg $12.357B 0.00
CochLear (CHEOY) Australia $11.324B 0.00
Revvity (RVTY) United States $10.833B 18.64
ICON (ICLR) Ireland $10.585B 9.84
Viatris (VTRS) United States $10.364B 3.56
Doximity (DOCS) United States $9.697B 45.17
Avantor (AVTR) United States $8.886B 12.91
Medpace Holdings (MEDP) United States $8.538B 22.68
Sonic Healthcare (SKHHY) Australia $8.205B 0.00
Charles River Laboratories (CRL) United States $6.763B 13.25
Amplifon S.p.A (AMFPF) Italy $4.966B 27.18
Bausch + Lomb (BLCO) Canada $4.142B 24.42
BrightSpring Health Services (BTSG) United States $4.077B 37.74
Sotera Health (SHC) United States $3.514B 19.97
Alignment Healthcare (ALHC) United States $2.948B 0.00
Surgery Partners (SGRY) United States $2.922B 38.00
Concentras Parent (CON) United States $2.767B 15.99
Organon (OGN) United States $2.480B 2.64
Ardent Health Partners (ARDT) United States $2.103B 8.96
GeneDx Holdings (WGS) United States $1.997B 76.90
Premier (PINC) United States $1.891B 14.36
Progyny (PGNY) United States $1.829B 40.26
PACS (PACS) United States $1.513B 0.00
GoodRx Holdings (GDRX) United States $1.361B 27.21
Teladoc Health (TDOC) United States $1.225B 0.00
Pediatrix Medical (MD) United States $1.222B 9.30
Ryman Healthcare (RYHTY) New Zealand $1.011B 0.00
Establishment Labs Holdings (ESTA) $1.003B 0.00
Agilon Health (AGL) United States $0.923B 0.00
CareDx (CDNA) United States $0.922B 14.40
Nutex Health (NUTX) United States $0.921B 13.91
AMN Healthcare Services Inc (AMN) United States $0.807B 7.56
QDM (QDMI) Hong Kong, SAR China $0.743B 0.00
Embecta (EMBC) United States $0.611B 4.12
InnovAge Holding (INNV) United States $0.547B 0.00
Enhabit (EHAB) United States $0.523B 43.04
LifeMD (LFMD) United States $0.522B 0.00
Auna S.A (AUNA) Luxembourg $0.482B 10.85
SBC Medicals (SBC) United States $0.482B 0.00
Sonida Senior Living (SNDA) United States $0.461B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.387B 0.00
Oncology Institute (TOI) United States $0.286B 0.00
Performant Healthcare (PHLT) United States $0.224B 0.00
Beauty Health (SKIN) United States $0.203B 0.00
KindlyMD (KDLY) United States $0.150B 0.00
DocGo (DCGO) United States $0.139B 22.67
KindlyMD (NAKA) United States $0.135B 0.00
OncoCyte (OCX) United States $0.093B 0.00
So-Young (SY) China $0.093B 0.00
Ascend Wellness Holdings (AAWH) United States $0.069B 0.00
Sera Prognostics (SERA) United States $0.062B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.057B 0.00
Biodesix (BDSX) United States $0.048B 0.00
Pheton Holdings (PTHL) China $0.039B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.032B 0.00
Basel Medical Group (BMGL) Singapore $0.019B 0.00
ModivCare (MODV) United States $0.019B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
Intelligent Bio Solutions (INBS) United States $0.010B 0.00
Co-Diagnostics (CODX) United States $0.010B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
INVO Fertility (IVF) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00